The aim of this workshop is to explore the relationship between dehumanisation and transphobia. There has been an uptick in philosophical attention to dehumanisation in recent years\, yet its application to trans experience remains underexplored. This gap is especially troubling given the recent rapid rise in transphobic rhetoric and anti-trans policies\, especially in the US and the UK. This workshop seeks to bring together philosophers and scholars from cognate disciplines to explore the possibilities and limitations of analysing transphobia through the lens of dehumanisation.
\nInvited speakers:
\nAustralia is at the centre of this shift. In 2020\, Monash University established the country's first dedicated psychedelic research lab. In 2023\, the Therapeutic Goods Administration created a regulated pathway for authorised psychiatrists to prescribe MDMA and psilocybin\, making Australia one of the first countries to formalise clinical access to psychedelic-assisted therapy outside of clinical trials.
\nMultiple groups across the Asia-Pacific are now conducting world-first and world-class psychedelic research\, assessing implementation in real-world clinics\, asking questions across a diverse array of disciplines\, manufacturing psychedelic compounds in novel ways\, shaping novel policy\, and developing psychedelic practice.
\nCAPS27 builds on that foundation. It's a forum for researchers\, clinicians\, policymakers\, ethicists\, cultural scholars\, educators\, industry leaders\, and funders to meet\, share evidence\, build collaborations\, and advance the field together.
ORGANIZER: METHOD:PUBLISH END:VEVENT END:VCALENDAR